Basal characteristics of patients infected with COVID-19
| Variable | National Institutes of Health clinical spectrum | P-value | |||
|---|---|---|---|---|---|
| Total (n=214) |
Asymptomatic/mild illness (n=104) |
Moderate illness (n=63) |
Severe/critical illness (n=47) |
||
| Age (y) | 47.0±17.9 | 37.6±14.3 | 51.4±15.3 | 62.0±14.8 | <0.001 |
| Body mass index |
23.4±3.5 | 22.8±3.7 | 23.9±3.2 | 23.9±3.4 | 0.062 |
| Sex | 0.937 | ||||
| Female | 156 (72.9) | 76 (73.1) | 45 (71.4) | 35 (74.5) | |
| Male | 58 (27.1) | 28 (26.9) | 18 (28.6) | 12 (25.5) | |
| Comobidities | |||||
| Hypertension | 37 (17.3) | 9 (8.7) | 11 (17.5) | 17 (36.2) | <0.001 |
| Diabetes mellitus | 25 (11.7) | 3 (2.9) | 6 (9.5) | 16 (34.0) | <0.001 |
| Coronary artery disease | 11 (5.1) | 3 (2.9) | 3 (4.8) | 5 (10.6) | 0.149 |
| Cerebrovascular disease | 7 (3.3) | 2 (1.9) | 3 (4.8) | 2 (4.3) | 0.531 |
| Malignancy | 11 (5.1) | 4 (3.8) | 2 (3.2) | 5 (10.6) | 0.197 |
| HBV infection | 4 (1.9) | 3 (2.9) | 1 (1.6) | 0 (0) | 0.813 |
| Chronic kidney disease | 3 (1.4) | 1 (1.0) | 0 (0) | 2 (4.3) | 0.204 |
| Pulmonary tuberculosis | 3 (1.4) | 2 (1.9) | 1 (1.6) | 0 (0) | >0.999 |
| Asthma/COPD | 7 (3.3) | 2 (1.9) | 1 (1.6) | 4 (8.5) | 0.076 |
| Hypothyroidism | 5 (2.3) | 2 (1.9) | 2 (3.2) | 1 (2.1) | 0.849 |
Values are presented as number (%) or mean±standard deviation.
COVID-19, coronavirus disease 2019; HBV, hepatitis B virus; COPD, chronic obstructive pulmonary disease.
aP-value by ANOVA. bData available for 198 patients.
P-value was calculated by chi-square test.